Nasus Pharma Ltd.
General ticker "NSRX" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $37.0M (TTM average)
Nasus Pharma Ltd. does not follow the US Stock Market performance with the rate: -21.3%.
Estimated limits based on current volatility of 3.6%: low 2.60$, high 2.80$
Factors to consider:
- Total employees count: 7 as of 2025
Short-term NSRX quotes
Long-term NSRX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $1.15MM | $1.08MM | $4.90MM |
| Operating Income | $-1.15MM | $-1.08MM | $-4.90MM |
| Non-Operating Income | $0.14MM | $-0.47MM | $-0.90MM |
| Interest Expense | $0.05MM | $0.03MM | $0.00MM |
| R&D Expense | $0.57MM | $0.34MM | $2.24MM |
| Income(Loss) | $-1.00MM | $-1.55MM | $-5.80MM |
| Net Income(Loss)* | $-1.05MM | $-1.53MM | $-5.86MM |
| Stockholders Equity | $-3.80MM | $-3.21MM | $2.77MM |
| Assets | $0.44MM | $0.72MM | $5.00MM |
| Operating Cash Flow | $-1.03MM | $-0.67MM | $-4.92MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.01MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-3.01MM |
| Financing Cash Flow | $1.05MM | $0.77MM | $8.92MM |
| Earnings Per Share** | $-0.12 | $-0.17 | $-0.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.